Visit U.S. website

(+45) 45 29 00 00 | info@bioporto.com

Bioporto
  • Products
    • The NGAL Test
    • Antibodies
    • ELISA Kits
    • Lateral Flow
  • News
  • Investor Relations
    • Investor Dashboard
    • Investor Contact
    • Shareholder Portal
    • Analyst Coverage
    • Governance
  • About
    • About BioPorto
    • Antibody Licensing
    • Clinical Research
    • Events
    • Careers
  • Contact
    • Connect with Us
    • Customer Care
    • FAQs

Presentations

Return to Dashboard

Interim Report, first half 0f 2019

Investor Meeting Q2 2019 – 15 August 2019
 

Extraordinary General Meeting 2019

15 August 2019
 

Interim Report Q1 2019 

9 May 2019
 

Annual General Meeting 2019

18 March 2019
 

Annual Report 2018

22 February 2019
 

Biotech Showcase

8 January 2019

Page last updated – 2019/11/01

  • Investor Relations
  • Careers
  • News
  • Governance
    • Terms of Use
    • Code of Conduct
    • Cookie Disclaimer
    • Data Protection
    • Patent Marking
    • Quality Policy
Join our Mailing List

Sign Up

BIOPORTO DIAGNOSTICS A/S  |  TUBORG HAVNEVEJ 15, ST.  |  DK-2900 HELLERUP  |  DENMARK  |  (+45) 45 29 00 00  |  INFO@BIOPORTO.COM

©2019 BioPorto A/S

This site uses functional cookies and external scripts to improve your experience.

More information
Privacy SettingsCookies

Privacy Settings

This site uses functional cookies and external scripts to improve your experience. Which cookies and scripts are used and how they impact your visit is specified on the left. You may change your settings at any time. Your choices will not impact your visit.

Opting Out

View Cookie Details

NOTE: These settings will only apply to the browser and device you are currently using.

Cookies

The following is a list of the cookies you are agreeing to.

__utmb : Google Analytics

__utmc : Google Analytics

__utmz : Google Analytics

__utma : Google Analytics

__utmt_UA-200684-3 : Google Analytics

wpgdprc-consent-4 : BioPorto.com

products-overlay : BioPorto.com

View Cookie Details

Accept